FDA Approves Daxxify, a New Anti-Wrinkle Drug – The New York Times
Business News
- FDA Approves Daxxify, a New Anti-Wrinkle Drug The New York Times
- FDA Approves New Botox Rival The Wall Street Journal
- Botox rival’s longer-lasting wrinkle eraser approved by FDA: ‘It’s a big deal’ New York Post
- FDA signs off on Revance’s Daxxify, which will take on Botox FiercePharma
- Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results Yahoo Finance
- View Full Coverage on Google News
Source: Business News